share_log

東瑞製葯:2022 中期報告

DAWNRAYS PHARMA: 2022 INTERIM REPORT

Sep 15, 2022 05:34
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more